Skip to content
thispeptide

Vaylen

Vaylen advertises clinician-reviewed compounded weight-management treatment with monthly check-ins. Its public pages disagree about the clinical partner, while the lowest price requires paying for a year.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

The stated care and payment sequence is clear in places, but the responsible medical practice needs confirmation. A flexible monthly plan is easier to evaluate than a year-long commitment before clinical continuity is understood.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Semaglutide injection, from $129/mo

Visit Vaylen →

Vaylen is a technology and care-coordination platform with an active weight-management program. Its homepage labels several other categories as pre-launch, so those should not be treated as current prescribing services. The weight-loss page offers semaglutide and tirzepatide injections and a daily dissolvable semaglutide tablet. The preparations are described as compounded, rather than approved generics. The injection and tablet options have different evidence questions and should not be selected only by their advertised price. Ask the clinician to identify the exact preparation and explain its intended role in the individual treatment plan.

What Vaylen prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $129/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $179/mo

Semaglutide and tirzepatide injections are named explicitly, with a separate daily dissolvable tablet offer. The page quotes weight-loss findings from clinical trials of the active ingredients. Those results should not automatically be applied to every compounded preparation or route. In particular, a dissolvable tablet should not be assumed equivalent to an injection because the ingredient name is shared. Ask how the proposed tablet is administered and what evidence supports that specific formulation. A lower price does not answer that clinical question.

Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The homepage and weight-management footer identify MDI Medical Group, P.C., arranged through MD Integrations. The linked terms and health-privacy page instead identify OpenLoop Health. Those are different clinical relationships, so the responsible practice should be confirmed before consenting to treatment. The platform itself is not a medical provider or dispenser. Ask which legal medical entity and licensed professional will review the intake, prescribe and handle later questions. The site says the pharmacy name appears on the prescription and medication label, but does not identify the dispenser for every order in advance.

The program describes an online health questionnaire followed by individual clinician review. The website says approval is not automatic and advertises review within twenty-four hours. The plan includes monthly check-ins, potential dose adjustments and care-team messaging. These are useful stated follow-up features, but a patient should distinguish administrative messaging from immediate access to the treating professional. Ask how a live conversation is arranged and when the clinician refers a problem for in-person assessment. The exact practice should be resolved before relying on a continuing relationship through a long prepaid term.

Are labs required?

Not mentioned

The public weight-management offer does not establish a complete universal laboratory panel or testing amount. Ask what recent results are needed before prescribing, how any new tests are arranged and whether those costs fall within the plan. A questionnaire is a way to collect medical history, not proof that bloodwork or examination is unnecessary. The responsible clinician should also explain how to investigate symptoms during treatment. Broad all-in care language needs a product-specific explanation of testing rather than an assumption that every outside medical service is included.

Ready to start with Vaylen?

Lowest listed price: Semaglutide injection, from $129/mo. Confirm it on the seller’s own site.

What it claims, and what it cites

Vaylen emphasizes substantial weight-loss potential, same-dose pricing and rapid delivery. Its clinical references concern particular studied medicines and populations, while its footer acknowledges that compounded drugs are not FDA-approved finished products. Keep those limitations attached to the benefit claim. The terms also explain that imagery can be illustrative. Photographs and selected testimonials therefore should not substitute for clinical evidence or identify who will provide care. The clearest practical issue is the conflict in named clinical partners, which deserves resolution before paying for many months of treatment.

Other products and treatment claims

Other advertised specialty categories
Men’s health, women’s health, hair loss and longevity are labeled pre-launch rather than active programs.

How it bills

The public semaglutide injection offer is $129 for month-to-month treatment, while the $83 equivalent requires $996 paid once for twelve months. The tirzepatide injection tab shows $179 monthly or $1,488 for the year. The tablet tab shows $149 monthly or $1,188 for the year. Monthly plans can be canceled through the portal before renewal without a minimum term. Approved prepaid programs are nonrefundable once underway. Confirm the actual preparation, testing scope and responsible medical practice before choosing the longer commitment.

For and against

  • For: Monthly clinical check-ins described
  • For: Separate monthly and prepaid amounts disclosed
  • For: Portal cancellation for monthly plans
  • For: Approval remains an individual clinical decision
  • Against: Clinical partner differs between current documents
  • Against: Lowest headline requires a year paid up front
  • Against: Prepaid treatment becomes nonrefundable once underway
  • Against: Tablet administration and testing need clarification

The evidence behind what it sells

Right for

Someone seeking the stated monthly follow-up who will verify the actual medical practice and preparation before making a financial commitment.

Look elsewhere if

A patient choosing a year-long plan solely from the $83 equivalent or assuming the dissolvable tablet shares injection evidence.

Other sellers for weight

Vaylen

Frequently asked questions

Which practice provides Vaylen treatment?
Current pages name MDI Medical Group and MD Integrations, while linked terms identify OpenLoop Health. Ask which entity and clinician handle the actual case.
Are the other specialty categories open for treatment?
The homepage labels several categories pre-launch. That does not establish active medication availability in those areas.
Does the lowest headline buy one independent month?
No. The $83 semaglutide equivalent requires a $996 twelve-month purchase. The public independent monthly injection option is $129.
Can a prepaid program be refunded after approval?
The policy says approved prepaid programs are nonrefundable once the program is underway. Monthly renewal has a separate cancellation process.

Sources

  • Current program, product tabs and monthly care features
  • Named medical partner and pre-launch categories
  • Clinical-entity and program contract
  • Monthly cancellation and prepaid refund limits
  • Named covered clinical entities
  • Consent to remote medical care

See what Vaylen prescribes today

Vaylen sets its own prices, plans and the states it serves. Check them before you start.

Written by Leah Garner from Vaylen’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.